Page 81 - Read Online

Page 16 of 16 Chávez-López et al. Hepatoma Res 2020;6:14 I http://dx.doi.org/10.20517/2394-5079.2019.023

upregulated VGSC beta1 subunit. Tumour Biol 2016;37:3033-41.
125. He Z, Dong W, Hu J, Ren X. AQP5 promotes hepatocellular carcinoma metastasis via NF-kappaB-regulated epithelial-mesenchymal
transition. Biochem Biophy Res Commun 2017;490:343-8.
126. Zhang Z, Han Y, Sun G, Liu X, Jia X, et al. MicroRNA-325-3p inhibits cell proliferation and induces apoptosis in hepatitis B virus-
related hepatocellular carcinoma by down-regulation of aquaporin 5. Cell Mol Biol Lett 2019;24:13.
127. Li CF, Zhang WG, Liu M, Qiu LW, Chen XF, et al. Aquaporin 9 inhibits hepatocellular carcinoma through up-regulating FOXO1
expression. Oncotarget 2016;7:44161-70.
128. Zhang WG, Li CF, Liu M, Chen XF, Shuai K, et al. Aquaporin 9 is down-regulated in hepatocellular carcinoma and its over-expression
suppresses hepatoma cell invasion through inhibiting epithelial-to-mesenchymal transition. Cancer Lett 2016;378:111-9.
129. Xu J, Yang Y, Xie R, Liu J, Nie X, et al. The NCX1/TRPC6 complex mediates TGFbeta-driven migration and invasion of human
hepatocellular carcinoma cells. Cancer Res 2018;78:2564-76.
130. Tian Y, Zhu MX. A novel TRPC6-dependent mechanism of TGF-beta-induced migration and invasion of human hepatocellular carcinoma
cells. Sci China Life Sci 2018;61:1120-2.
131. Wen L, Liang C, Chen E, Chen W, Liang F, et al. Regulation of multi-drug resistance in hepatocellular carcinoma cells is TRPC6/calcium
dependent. Sci Rep 2016;6:23269.
132. Selli C, Erac Y, Kosova B, Erdal ES, Tosun M. Silencing of TRPC1 regulates store-operated calcium entry and proliferation in Huh7
hepatocellular carcinoma cells. Biomed Pharmacother 2015;71:194-200.
133. Selli C, Pearce DA, Sims AH, Tosun M. Differential expression of store-operated calcium- and proliferation-related genes in
hepatocellular carcinoma cells following TRPC1 ion channel silencing. Mol Cell Biochem 2016;420:129-40.
134. Miao X, Liu G, Xu X, Xie C, Sun F, et al. High expression of vanilloid receptor-1 is associated with better prognosis of patients with
hepatocellular carcinoma. Cancer Genet Cytogenet 2008;186:25-32.
135. Chen WT, Lin GB, Lin SH, Lu CH, Hsieh CH, et al. Static magnetic field enhances the anticancer efficacy of capsaicin on HepG2 cells
via capsaicin receptor TRPV1. PloS One 2018;13:e0191078.
136. Hu Z, Cao X, Fang Y, Liu G, Xie C, et al. Transient receptor potential vanilloid-type 2 targeting on stemness in liver cancer. Biomed
Pharmacother 2018;105:697-706.
137. Fang Y, Liu G, Xie C, Qian K, Lei X, et al. Pharmacological inhibition of TRPV4 channel suppresses malignant biological behavior of
hepatocellular carcinoma via modulation of ERK signaling pathway. Biomed Pharmacother 2018;101:910-9.
138. Chen Y, Yu Y, Sun S, Wang Z, Liu P, et al. Bradykinin promotes migration and invasion of hepatocellular carcinoma cells through TRPM7
and MMP2. Exp Cell Res 2016;349:68-76.
139. Jin C, Ye QH, Yuan FL, Gu YL, Li JP, et al. Involvement of acid-sensing ion channel 1alpha in hepatic carcinoma cell migration and
invasion. Tumour Biol 2015;36:4309-17.
140. Pittala S, Krelin Y, Shoshan-Barmatz V. Targeting liver cancer and associated pathologies in mice with a mitochondrial VDAC1-based
peptide. Neoplasia 2018;20:594-609.
141. Guerra MT, Florentino RM, Franca A, Lima Filho AC, Dos Santos ML, et al. Expression of the type 3 InsP3 receptor is a final common
event in the development of hepatocellular carcinoma. Gut 2019;68:1676-87.
142. Hartke J, Johnson M, Ghabril M. The diagnosis and treatment of hepatocellular carcinoma. Semin Diagn Pathol 2017;34:153-9.
143. Stühmer W, Alves F, Hartung, F, Zientkowska M, Pardo LA. Potassium channels as tumour markers. FEBS Lett 2006;580:2850-2.
144. Black JA, Waxman SG. Noncanonical roles of voltage-gated sodium channels. Neuron 2013;80:280-91.
145. Downie BR, Sánchez A, Knötgen H, Contreras-Jurado C, Gymnopoulos M, et al. Eag1 expression interferes with hypoxia homeostasis
and induces angiogenesis in tumors. J Biol Chem 2008;283:36234-40.
146. Buchanan PJ, McCloskey KD. Ca V channels and cancer: canonical functions indicate benefits of repurposed drugs as cancer therapeutics.
Eur Biophys J 2016;45:621-33.
147. Lee H, Kang S, Kim W. Drug repositioning for cancer therapy based on large-scale drug-induced transcriptional signatures. PloS One
2016;11:e0150460.
148. Ellegaard AM, Dehlendorff C, Vind AC, Anand A, Cederkvist L, et al. Repurposing cationic amphiphilic antihistamines for cancer
treatment. EBioMedicine 2016;9:130-9.